Filter
3940
Filtered Results: 3940
Text search:
Center
for
Disease
Control
Featured
Recommendations
336
New Publications
1012
Language
Document type
No document type
2231
Studies & Reports
685
Guidelines
503
Manuals
199
Strategic & Response Plan
104
Fact sheets
84
Training Material
60
Situation Updates
41
Infographics
11
Resource Platforms
10
Online Courses
5
Brochures
4
Videos
2
App
1
Countries / Regions
India
190
Global
131
Ethiopia
115
Liberia
96
Kenya
90
Nepal
88
Rwanda
84
Latin America and the Carribbean
73
Sierra Leone
71
Africa
66
Nigeria
65
Uganda
61
Bangladesh
55
Western and Central Europe
53
Philippines
52
Malawi
49
Tanzania
47
Congo, Democratic Republic of
45
Myanmar / Burma
45
Ukraine
41
Zambia
39
Mozambique
39
Syria
38
Haiti
37
Russia
37
Cambodia
33
Ghana
32
Brazil
32
Guinea
30
Senegal
30
Indonesia
30
Eastern Europe
30
South Africa
28
Asia
26
South Sudan
24
Burkina Faso
21
Namibia
21
Lesotho
20
Yemen
19
Zimbabwe
18
South–East Asia Region
18
Germany
17
West and Central Africa
16
USA
15
Cameroon
15
Colombia
15
Angola
15
Middle East and North Africa
15
Eastern Europe and Central Asia
13
Venezuela
12
Argentina
11
East and Southern Africa
11
Thailand
10
Ecuador
9
Botswana
9
Albania
9
Afghanistan
8
Western Pacific Region
8
Guinea-Bissau
7
Pakistan
7
Jordan
7
Benin
7
Eswatini/ Swaziland
7
Chile
7
Paraguay
7
Georgia
7
Vietnam
7
Mali
6
China
6
Central African Republic
6
Peru
6
Armenia
6
Somalia
5
Chad
5
Bolivia
5
Madagascar
5
Laos
5
Tajikistan
5
Moldova
5
North America
5
Côte d’Ivoire / Ivory Coast
4
Sri Lanka
4
Japan
4
France
4
Niger
3
Iraq
3
North Macedonia
3
Burundi
3
Honduras
3
El Salvador
3
Mexico
3
Palestine
3
Kazakhstan
3
United Kingdom
3
Portugal
3
Spain
3
Belarus
3
Saudi Arabia
2
Lebanon
2
Turkey
2
Malaysia
2
Sudan
2
Greece
2
Libya
2
Bhutan
2
Canada
2
Timor Leste/ East Timor
2
Romania
2
Iran
2
Kyrgyzstan
2
Gabon
2
Jamaica
2
Egypt
1
Papua New Guinea
1
Austria
1
Switzerland
1
Hungary
1
Other region
1
Fiji
1
Poland
1
Italy
1
Southern Africa
1
Qatar
1
Estonia
1
Lithuania
1
Turkmenistan
1
Belgium
1
Mauritius
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1484
Clinical Guidelines
307
Public Health
218
Women & Child Health
160
Key Resources
150
Capacity Building
67
Pharmacy & Technologies
43
Toolboxes
COVID-19
413
HIV
318
Mental Health
290
TB
230
AMR
165
Ebola
152
Planetary Health
134
NTDs
126
Rapid Response
119
Caregiver
95
NCDs
79
Conflict
71
Disability
68
Global Health Education
67
Pharmacy
58
Refugee
57
Zika
53
Natural Hazards
51
Cholera
40
Health Financing Toolbox
37
Specific Hazards
25
Polio
15
Social Ethics
7
Typhoon
2
Health Financing
2
South Sudan
1
The Global Sexual and Reproductive Health Service Package for Men and Adolescent Boys has been developed to support providers of sexual and reproductive health (SRH) services to increase the range and quality of services to meet the specific and div...
Policy Guidance Brief 2
• The potential health risks from climate change include: increase of waterborne and vector-borne diseases, heat-related illnesses, injuries and deaths, food insecurity and increased malnutrition. The poor, women, chil...
• The potential health risks from climate change include: increase of waterborne and vector-borne diseases, heat-related illnesses, injuries and deaths, food insecurity and increased malnutrition. The poor, women, chil...
On 17 October 2017, the Ugandan Ministry of Health notified WHO of a confirmed Marburg outbreak of Marburg Virus disease (MVD) in Kween district, Eastern Uganda. The outbreak was officially declared by the Ministry of health on 19 October 2017.
As ...
In response to the COVID-19 outbreak this risk communication package for healthcare facilities provides healthcare workers (HCWs) and healthcare facility management with the information, procedures, and tools required to safely and effectively work....
. Interim Guidelines. This interim guideline lays out some basic principles of optimal nutritional care for adults and paediatric patients during treatment and convalescence in Ebola treatment units, community care centres or to other centres where ...
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – f... pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community pharmacies and primary healthcare facilities) and in
hospital settings, as well as for pharmacists working as clinical biologists in medical
analysis laboratories, for example, as clinical biologists, and offer a set of references that
may be consulted for more informationstor
Bioethics 519 (online) doi:10.1111/bioe.12145 Volume 29 Number 8 2015 pp. 488–596;
Pandemic plans recommend phases of response to an emergent infectious disease (EID) outbreak, and are primarily aimed at preventing and mitigating human-to-human ...
Following the release of the Wheelchair Service Training Package – Basic level (WSTP-B), WHO in partnership with United States Agency for International Development (USAID) has developed the Wheelchair Service Training Package – Intermediate Lev...
Maternal mortality has fallen significantly in recent years, especially in countries that have emphasized the prevention of its main causes, such as hemorrhagic and infectious complications and hypertension , including in the Region of the Americas. In its final report on the Plan of Action to Accel...
Traditional food markets play important economic, cultural, and social role and are sources of livelihood for millions of people in urban and rural areas. The manual Five keys for safer traditional ...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of pub...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable ... (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
n the countries of the Region of the Americas, there are different forms of organization of health services at the first level of care. Some countries include certain laboratory, dental and diagnostic imaging practices in the first level of care, while other countries centralize these practices in t...
Advances in the treatment of pediatric cancer have made it possible to expand initiatives beyond cure and cover aspects such as early detection, continuity of treatment and reduction in toxicity. All this has paved the way for a more comprehensive v...
A series of information sheets to help empower communities and strengthen health systems
This series of information sheets introduces health literacy, its
relevance to public policy, and the ways it can be used to inform
the promotion of good health, the prevention and management
of communicab...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the ...’s spread and evolution of the virus. Accelerated integration of genome sequencing into the practices of the global health community is required if we want to be better prepared for the future threats. This document provides guidance for laboratories on maximizing the impact of SARS-CoV-2 sequencing now and other emerging pathogens in the future.
This guidance note is meant to assist humanitarian actors, youth-led organizations, and young people themselves across sectors, working at local, country, regional, and global levels in their response to the novel coronavirus pandemic. It begins diagnostically, exploring the impacts of coronavirus <... (COVID-19) on young people. It then proposes a series of actions that practitioners and young people can take to ensure that COVID-19 preparedness, response plans and actions, are youth-inclusive and youth-focused – with and for young people. Recommendations are structured around the five key actions of the Compact for Young People in Humanitarian Action: services, participation, capacity, resources, and data. Where available, the recommended actions are accompanied by resources and concrete examples, which can inform approaches and support implementation
Updated on 6 APRIL 2020
There are serious concerns that the situation might escalate in the next weeks modelling the epi curve of other regions. The interlinkages between human mobility and the current pandemic of COVID-19 are well established, and while international flights have been suspended i...
People-centered approaches that help communities maintain protective behaviours and follow guidelines set out by public health and government agencies are more important than ever. The evidence is clear, communities play a role in preventing and control...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access ... clarity. The publication of the RECOVERY and REMAP-CAP randomised controlled trials triggered this guideline update, resulting in a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19.
Prior recommendations: (a) A recommendation not to use ivermectin in patients with covid-19, regardless of disease severity, except in the context of a clinical trial; (b) a strong recommendation against the use of hydroxychloroquine in patients with covid-19, regardless of disease severity; (c) a strong recommendation against the use of lopinavir-ritonavir in patients with covid-19, regardless of disease severity; (d) a strong recommendation for systemic corticosteroids in patients with severe and critical covid-19; (e) a conditional recommendation against systemic corticosteroids in patients with non-severe covid-19; and (f) a conditional recommendation against remdesivir in hospitalised patients with covid-19.
